Last reviewed · How we verify
silymarin 0.7% cream
silymarin 0.7% cream is a Small molecule drug developed by Islamabad Medical and Dental College. It is currently in Phase 2 development.
At a glance
| Generic name | silymarin 0.7% cream |
|---|---|
| Sponsor | Islamabad Medical and Dental College |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Silymarin Cream Versus Combined Silymarin Cream and Microneedling in Treatment of Melasma (PHASE4)
- Comparison of Topical Silymarin With Hydroquinone in the Treatment of Melasma (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- silymarin 0.7% cream CI brief — competitive landscape report
- silymarin 0.7% cream updates RSS · CI watch RSS
- Islamabad Medical and Dental College portfolio CI
Frequently asked questions about silymarin 0.7% cream
What is silymarin 0.7% cream?
silymarin 0.7% cream is a Small molecule drug developed by Islamabad Medical and Dental College.
Who makes silymarin 0.7% cream?
silymarin 0.7% cream is developed by Islamabad Medical and Dental College (see full Islamabad Medical and Dental College pipeline at /company/islamabad-medical-and-dental-college).
What development phase is silymarin 0.7% cream in?
silymarin 0.7% cream is in Phase 2.
Related
- Manufacturer: Islamabad Medical and Dental College — full pipeline
- Compare: silymarin 0.7% cream vs similar drugs
- Pricing: silymarin 0.7% cream cost, discount & access